Sangamo Therapeutics, Inc. (SGMOQ)
0.105
0.00 (0.00%)
USD |
OTCM |
Oct 21, 16:00
Sangamo Therapeutics Net Income (Annual) : -122.93M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -122.93M |
| December 31, 2024 | -97.94M |
| December 31, 2023 | -257.83M |
| December 31, 2022 | -192.28M |
| December 31, 2021 | -178.30M |
| December 31, 2020 | -121.12M |
| December 31, 2019 | -95.42M |
| December 31, 2018 | -68.89M |
| December 31, 2017 | -54.57M |
| December 31, 2016 | -71.66M |
| December 31, 2015 | -40.70M |
| December 31, 2014 | -26.42M |
| December 31, 2013 | -26.62M |
| December 31, 2012 | -22.26M |
| Date | Value |
|---|---|
| December 31, 2011 | -35.75M |
| December 31, 2010 | -24.85M |
| December 31, 2009 | -18.59M |
| December 31, 2008 | -24.30M |
| December 31, 2007 | -21.48M |
| December 31, 2006 | -17.86M |
| December 31, 2005 | -13.29M |
| December 31, 2004 | -13.82M |
| December 31, 2003 | -10.43M |
| December 31, 2002 | -29.76M |
| December 31, 2001 | -25.25M |
| December 31, 2000 | -9.066M |
| December 31, 1999 | -3.775M |
| December 31, 1998 | -3.285M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sarepta Therapeutics, Inc. | -713.41M |
| Anixa Biosciences, Inc. | -11.03M |
| Vicapsys Life Sciences, Inc. | -0.6899M |